Welcome to the European Society for Translational Antiviral Research

The European Society for translational Antiviral Research (ESAR) aims to unite scientists and clinicians throughout Europe to expand knowledge on resistant viruses and to investigate the molecular epidemiology of drug-resistant viruses in Europe from Public Health and scientific perspectives. ESAR will acts as a collaborative non-profit network for scientific studies, quality control, guidelines and training activities.

For more information about the Society please follow this link.


Scientists map the global spread of HIV – through the Western world and beyond – for the first time

For the first time, an international team of scientists from the European Society for Translational Antiviral Research (ESAR: esar-society.eu) has mapped the spread of the HIV virus around the globe after it reached the United States in the early 1970s.READ MORE>>

ESAR Fall 2017 meeting
Tuesday October 31st, 2017
Cologne, Germany

Recent publications

Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance
Eurosurveillance, Volume 22, Issue 11, 16 March 2017

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries.
Virus Evolution: 27 April 2016

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clin Infect Dis. 2016 Mar 1;62(5):655-63.

Button SPREAD database   map

Button HepCare Database.JPG